Viruses involved in allograft recipients' cutaneous carcinomas;Virus impliqués dans les carcinomes cutanés des greffés rénaux

Annales de Dermatologie et de Venereologie

Volumn 128, Issue 8-9, 2001, Pages 871-875

  Parant, E ^a   Jumbou, O ^a   Dantal, J ^b   Hourmant, M ^b   Dreno, B ^a  

^a CLINIQUE DERMATOLOGIQUE   (France)

^b HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; HUMAN; IN SITU HYBRIDIZATION; KIDNEY ALLOGRAFT; MALE; PAPILLOMA VIRUS; PREVALENCE; RECIPIENT; SKIN CANCER; SQUAMOUS CELL CARCINOMA; VIRUS GENE;

ADULT; AGED; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0034784779     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Malignant disease in patients with long terme renal transplantation
2. Malignancy following renal transplantation
3. Incidence and type of malignancies occuring after renal transplantation in conventionally and cyclosporine-treated recipients: Analysis of a 20 year period in 1600 patients
4. Skin cancers in transplant patients
5. Association of skin malignancies with various and multiples carcinogenic and non carcinogenic human papillomaviruses in renal transplant recipients
6. Prevalence of human papilloma virus in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion
7. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy
8. Human papilloma virus infection and skin cancer in renal allograft recipient
9. Ebstein-Barr virus in squamous cell carcinoma after renal transplantation
10. Specific expression of Ebstein-Barr virus in cutaneous squamous cell carcinomas from heart transplant recipients
11. Triple therapy and incidence of de novo cancer in renal transplant recipients
12. Cancer in the dialysis and transplant patients
13. HPV infections and immunosuppression
14. A possible role for human papillomaviruses and c-myc, c-Ha-ras and p53 gene alteration in malignant cutaneous lesions from transplant recipients
15. Human papillomaviruses in non melanoma skin cancer from renal transplant recipients and on immunosupressed patients
16. Influence of fixation on human papillomavirus DNA detection in frozen and embedded paraffin lesions by in situ hybridization with biotinylated probes
17. Association of skin malignancies with various and multiples carcinogenic and non carcinogenic human papillomaviruses in renal transplant recipients
18. Monitoring of CMV infection after renal transplantation: Serology, culture, and viral detection by hybrid capture
19. Subclinical pneumonitis during cytomegalovirus infection after kidney transplantation
20. Cytomegalovirus-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load
21. The clinical significance of cytomegaloviral inclusion in the allograft kidney
22. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomised comparison of two cyclosporin regimens